Cordlife reaches legal settlement with Cryoviva
Cryoviva will pay damages for trademark, copyright infringement
MAINBOARD-listed Cordlife Group has reached an "amicable" legal settlement with fellow cord blood banking firm Cryoviva Singapore, with regard to the latter's "passing off and infringement of Cordlife's registered trademarks and copyrights".
Cryoviva will pay Cordlife damages for trademark and copyright infringement and the passing off of Cordlife's information on its websites. The extent of both cases of infringement and the quantum of damages will be assessed by the Singapore High Court, if not agreed by both parties.
Cryoviva will also pay Cordlife the total costs of the suit to date and the injunction application, if not agreed by both parties. A Cordlife spokesman said that as the company had yet to receive the billing from its legal advisers, it was unable to comment on suit costs.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Singapore stocks end week in red; STI down 0.1%
UK's FTSE 100 hits record highs on Anglo-American boost
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
SocGen Q1 profit slumps less than expected as investment bank surprises
WSJ moves Asia headquarters from Hong Kong to Singapore
Macquarie sees biggest profit dip in 15 years on commodities downturn